These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35294768)

  • 1. CHA
    Sonaglioni A; Lonati C; Rigamonti E; Viganò M; Nicolosi GL; Proietti M; Lombardo M; Harari S
    Aging Clin Exp Res; 2022 Jul; 34(7):1707-1720. PubMed ID: 35294768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of CHA
    Sonaglioni A; Caminati A; Re M; Elia D; Trevisan R; Granato A; Zompatori M; Lombardo M; Harari S
    Intern Emerg Med; 2023 Apr; 18(3):755-767. PubMed ID: 36966265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA
    Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.
    Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC
    JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R
    Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting stroke and death in patients with heart failure using CHA
    Son MK; Lim NK; Park HY
    BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CHA
    Marzouka GR; Rivner H; Mehta V; Lopez J; Vaz I; Tang F; Ishwaran H; Goldberger JJ
    Am J Cardiol; 2021 Sep; 155():72-77. PubMed ID: 34274114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke.
    Su CH; Lo CH; Chen HH; Tsai CF; Yip HT; Hsu KC; Hsu CY; Kao CH;
    PLoS One; 2022; 17(7):e0270823. PubMed ID: 35830440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA
    Xing Y; Sun Y; Li H; Tang M; Huang W; Zhang K; Zhang D; Zhang D; Ma Q
    Clin Interv Aging; 2018; 13():497-504. PubMed ID: 29636604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
    Hu WS; Lin CL
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1977-1986. PubMed ID: 36881169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
    Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
    ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
    Akboğa MK; Yılmaz S; Yalçın R
    Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CHA
    Yoshihisa A; Watanabe S; Kanno Y; Takiguchi M; Sato A; Yokokawa T; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    ESC Heart Fail; 2016 Dec; 3(4):261-269. PubMed ID: 27867527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the CHA
    Chua SK; Huang PS; Chen JJ; Chiu FC; Hwang JJ; Tsai CT
    Hellenic J Cardiol; 2024; 78():42-49. PubMed ID: 37633490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive interaction between chronic obstructive pulmonary disease and CHA
    Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
    Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.